Single Superior ILM/ERM Flap for the FTMH.

Omer Othman Abdullah5 enrolled

Overview

In this study, the investigators will make the only upper flap either from the internal limiting membrane or from the epiretinal membrane to cover the full thickness macular hole.

After the investigators completed the clinical trial NCT05269563, which was a double flap technique; that consists of two flaps from the internal limiting membrane and the epiretinal membrane. The inferior flap was implanted inside the hole, but the upper flap was utilized to cover the hole. The results were encouraging. Therefore, in this study, the investigators will make the only upper flap to cover the full thickness macular hole, to compare both visual and anatomical outcomes with the double flapped technique (NCT05269563) results. Therefore the double flap will be our control.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Ophthalmopathy

Interventions

Surgical interventionOTHER

Pars-plana vitrectomy.

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Full thickness macular hole Exclusion Criteria: * Lamellar and pseudo holes

Locations (1)

Omer Othman Abdullah

Erbil, Iraq

Outcomes

Primary Outcomes

Anatomical outcome

OCT

Time frame: The fourth weeks post-operatively

Secondary Outcomes

Functional outcome

Best corrected visual acuity

Time frame: The fourth week post-operatively.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.